Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul;71(7):791-801.
doi: 10.1002/iub.2018. Epub 2019 Feb 11.

Mitochondrial dysfunctions in barth syndrome

Affiliations
Review

Mitochondrial dysfunctions in barth syndrome

Sagnika Ghosh et al. IUBMB Life. 2019 Jul.

Abstract

Barth syndrome (BTHS) is a rare multisystemic genetic disorder caused by mutations in the TAZ gene. TAZ encodes a mitochondrial enzyme that remodels the acyl chain composition of newly synthesized cardiolipin, a phospholipid unique to mitochondrial membranes. The clinical abnormalities observed in BTHS patients are caused by perturbations in various mitochondrial functions that rely on remodeled cardiolipin. However, the contribution of different cardiolipin-dependent mitochondrial functions to the pathology of BTHS is not fully understood. In this review, we will discuss recent findings from different genetic models of BTHS, including the yeast model of cardiolipin deficiency that has uncovered the specific in vivo roles of cardiolipin in mitochondrial respiratory chain biogenesis, bioenergetics, intermediary metabolism, mitochondrial dynamics, and quality control. We will also describe findings from higher eukaryotic models of BTHS that highlight a link between cardiolipin-dependent mitochondrial function and its impact on tissue and organ function. © 2019 IUBMB Life, 9999(9999):1-11, 2019.

Keywords: Barth syndrome; cardiolipin; mitochondria.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Cardiolipin biosynthetic pathway.
(A) CL biosynthesis occurs exclusively in the mitochondria. CL precursor, PA, is transported from the OMM to the IMM via Ups1/Mdm35 to initiate the CL biosynthetic pathway. PA is converted to PG through three subsequent enzyme-catalyzed reactions by Tam41, Pgs1, and Gep4. Crd1 biosynthesizes nascent CL (CLp) from PG. CLp must then be remodeled to form mature CL (CLm) through sequential deacylation and reacylation reactions catalyzed by Cld1 and Taz1, respectively. Taz1 is localized to the OMM and the IMM facing the IMS. (B) Structures of CLp, MLCL, and CLm. ATP, adenosine triphosphate; ADP, adenosine diphosphate; CTP, cytidine triphosphate; PPi, pyrophosphate; CDP-DAG, cytidine diphosphate-diacylglycerol; CMP, cytidine monophosphate; PA, phosphatidic acid; CLp, premature cardiolipin; CLm, mature cardiolipin; MLCL, monolysocardiolipin; PG, phosphatidylglycerol; PGP, phosphatidylglycerol phosphate; G3P, glycerol-3-phosphate; PL, phospholipid; FA, fatty acid; OMM, outer mitochondrial membrane; IMM, inner mitochondrial membrane; IMS, intermembrane space.

References

    1. Barth PG, Scholte HR, Berden JA, Van der Klei-Van Moorsel JM, Luyt-Houwen IE, et al. (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. Neurol. Sci. 62, 327–355. - PubMed
    1. Clarke SL, Bowron A, Gonzalez IL, Groves SJ, Newbury-Ecob R, et al. (2013) Barth syndrome. Orphanet. J. Rare Dis. 8, 23. - PMC - PubMed
    1. Bione S, D’Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, et al. (1996) A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat. Genet. 12, 385–389. - PubMed
    1. Xu Y, Malhotra A, Ren M, and Schlame M (2006) The enzymatic function of tafazzin. J. Biol. Chem. 281, 39217–39224. - PubMed
    1. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, et al. (2002) Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann. Neurol. 51, 634–637. - PubMed

Publication types

Substances

LinkOut - more resources